CLINICAL CASE HISTORY OF EPTIFIBATIDE USE DURING CORONARY INTERVENTION IN PATIENT WITH CORONARY FAILURE

CLINICAL CASE HISTORY OF EPTIFIBATIDE USE DURING CORONARY INTERVENTION IN PATIENT WITH CORONARY FAILURE

Show other versions (1)

<p>Clinical case history of endovascular intervention in infarct related coronary artery with 4 sirolimus-eluting stents implantation and their further thrombosis during early postoperative period is described. Percutaneous coronary intervention was successful after the balanced medication wit...

Full description

Bibliographic Details
Main Authors: K. A. Kireev, A. V. Krasnopeev, T. S. Kireeva
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2015-09-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
острая коронарная патология
чрескожное коронарное вмешательство
тромбоз стента
эптифибатид
Online Access:http://www.rpcardio.ru/jour/article/view/122
id doaj-b2ba4c31547149f2a4f32980b46ef226
record_format Article
spelling doaj-b2ba4c31547149f2a4f32980b46ef2262020-11-24T22:33:50ZengStolichnaya Izdatelskaya KompaniyaRacionalʹnaâ Farmakoterapiâ v Kardiologii1819-64462225-36532015-09-0111215916410.1234/1819-6446-2015-2-159-164121CLINICAL CASE HISTORY OF EPTIFIBATIDE USE DURING CORONARY INTERVENTION IN PATIENT WITH CORONARY FAILUREK. A. Kireev0A. V. Krasnopeev1T. S. Kireeva2Дорожная клиническая больница на станции Челябинск, ОАО «РЖД», Южно-уральский государственный медицинский университетДорожная клиническая больница на станции Челябинск, ОАО «РЖД»Южно-уральский государственный медицинский университет<p>Clinical case history of endovascular intervention in infarct related coronary artery with 4 sirolimus-eluting stents implantation and their further thrombosis during early postoperative period is described. Percutaneous coronary intervention was successful after the balanced medication with 2 antiplatelet drugs (acetylsalicylic acid and clopidogrel) and heparin. There were not any reasons for additional prescription of antiplatelet medicine. It seems that one of the main reasons of the stent thrombosis was the extended area of 4 sirolimus-eluting stents implantation into the affected vessel. After the analysis of our clinical case history we propose that for stent thrombosis prevention in multistent (≥4 drugeluting stents) interventions it is necessary to apply additional antiplatelet drug – glycoprotein IIb/IIIa inhibitor eptifibatide.</p>http://www.rpcardio.ru/jour/article/view/122острая коронарная патологиячрескожное коронарное вмешательствотромбоз стентаэптифибатид
collection DOAJ
language English
format Article
sources DOAJ
author K. A. Kireev
A. V. Krasnopeev
T. S. Kireeva
spellingShingle K. A. Kireev
A. V. Krasnopeev
T. S. Kireeva
CLINICAL CASE HISTORY OF EPTIFIBATIDE USE DURING CORONARY INTERVENTION IN PATIENT WITH CORONARY FAILURE
Racionalʹnaâ Farmakoterapiâ v Kardiologii
острая коронарная патология
чрескожное коронарное вмешательство
тромбоз стента
эптифибатид
author_facet K. A. Kireev
A. V. Krasnopeev
T. S. Kireeva
author_sort K. A. Kireev
title CLINICAL CASE HISTORY OF EPTIFIBATIDE USE DURING CORONARY INTERVENTION IN PATIENT WITH CORONARY FAILURE
title_short CLINICAL CASE HISTORY OF EPTIFIBATIDE USE DURING CORONARY INTERVENTION IN PATIENT WITH CORONARY FAILURE
title_full CLINICAL CASE HISTORY OF EPTIFIBATIDE USE DURING CORONARY INTERVENTION IN PATIENT WITH CORONARY FAILURE
title_fullStr CLINICAL CASE HISTORY OF EPTIFIBATIDE USE DURING CORONARY INTERVENTION IN PATIENT WITH CORONARY FAILURE
title_full_unstemmed CLINICAL CASE HISTORY OF EPTIFIBATIDE USE DURING CORONARY INTERVENTION IN PATIENT WITH CORONARY FAILURE
title_sort clinical case history of eptifibatide use during coronary intervention in patient with coronary failure
publisher Stolichnaya Izdatelskaya Kompaniya
series Racionalʹnaâ Farmakoterapiâ v Kardiologii
issn 1819-6446
2225-3653
publishDate 2015-09-01
description <p>Clinical case history of endovascular intervention in infarct related coronary artery with 4 sirolimus-eluting stents implantation and their further thrombosis during early postoperative period is described. Percutaneous coronary intervention was successful after the balanced medication with 2 antiplatelet drugs (acetylsalicylic acid and clopidogrel) and heparin. There were not any reasons for additional prescription of antiplatelet medicine. It seems that one of the main reasons of the stent thrombosis was the extended area of 4 sirolimus-eluting stents implantation into the affected vessel. After the analysis of our clinical case history we propose that for stent thrombosis prevention in multistent (≥4 drugeluting stents) interventions it is necessary to apply additional antiplatelet drug – glycoprotein IIb/IIIa inhibitor eptifibatide.</p>
topic острая коронарная патология
чрескожное коронарное вмешательство
тромбоз стента
эптифибатид
url http://www.rpcardio.ru/jour/article/view/122
work_keys_str_mv AT kakireev clinicalcasehistoryofeptifibatideuseduringcoronaryinterventioninpatientwithcoronaryfailure
AT avkrasnopeev clinicalcasehistoryofeptifibatideuseduringcoronaryinterventioninpatientwithcoronaryfailure
AT tskireeva clinicalcasehistoryofeptifibatideuseduringcoronaryinterventioninpatientwithcoronaryfailure
_version_ 1725729155820027904

Similar Items